Cardiology Devices - Europe | Statista Market Forecast

The projected revenue in the Cardiology Devices market market in Europe is expected to reach US$20.46bn by 2024.
It is anticipated to grow at an annual growth rate (CAGR 2024-2029) of 5.12%, leading to a market volume of US$26.26bn by 2029.
When compared globally, the United States is expected to generate the highest revenue, amounting to US$25.77bn in 2024.
In Europe, Germany continues to dominate the Cardiology Devices market with its advanced medical technology and strong healthcare infrastructure.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

The Cardiology Devices market in Europe is experiencing steady growth due to various factors such as increasing prevalence of cardiovascular diseases, advancements in technology, and growing aging population.

Customer preferences: Customers in Europe are increasingly opting for minimally invasive procedures and devices that offer better patient outcomes and faster recovery times. They also prioritize devices that are user-friendly and provide accurate and reliable results. There is a growing demand for implantable devices such as pacemakers, defibrillators, and stents, as they offer long-term solutions for managing cardiovascular conditions.

Trends in the market: One of the key trends in the Cardiology Devices market in Europe is the shift towards remote monitoring and telemedicine. This allows healthcare professionals to monitor patients' cardiac health remotely, reducing the need for frequent hospital visits and improving patient convenience. Another trend is the development of advanced imaging technologies such as 3D echocardiography and cardiac MRI, which provide detailed images of the heart and help in accurate diagnosis and treatment planning. Additionally, there is a growing focus on personalized medicine, with the use of genetic testing and biomarkers to tailor treatment plans for individual patients.

Local special circumstances: Europe has a well-established healthcare infrastructure and a high level of healthcare expenditure, which contributes to the growth of the Cardiology Devices market. The region also has a strong regulatory framework for medical devices, ensuring safety and quality standards. Additionally, there is a high level of awareness about cardiovascular diseases among the population, leading to early detection and treatment.

Underlying macroeconomic factors: The aging population in Europe is a significant driver for the Cardiology Devices market, as the risk of cardiovascular diseases increases with age. Furthermore, the rising prevalence of lifestyle-related risk factors such as obesity, sedentary lifestyle, and unhealthy diet contribute to the growing demand for cardiology devices. The increasing healthcare expenditure and favorable reimbursement policies in many European countries also support the growth of the market. In conclusion, the Cardiology Devices market in Europe is witnessing steady growth driven by customer preferences for minimally invasive procedures, advancements in technology, and the aging population. The market is characterized by trends such as remote monitoring, advanced imaging technologies, and personalized medicine. Europe's well-established healthcare infrastructure, strong regulatory framework, and high level of awareness about cardiovascular diseases contribute to the market's growth. The underlying macroeconomic factors of an aging population, lifestyle-related risk factors, increasing healthcare expenditure, and favorable reimbursement policies further support the market's development.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.